ExodusPoint Capital Management, LP
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1736225
NEW YORK, NY
Position in IMDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$82,771
New position
Shares Held
14,029
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 40 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $101,462,417 across 18 Diagnostics & Research names. IMDX ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
164,518 | $24,682,635 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
32,661 | $16,374,918 | |
| 3 | QGEN |
Qiagen N.V.
|
321,161 | $12,557,395 | |
| 4 | A |
Agilent Technologies, Inc.
|
68,639 | $9,117,318 | |
| 5 | DHR |
Danaher Corp /De/
|
45,615 | $8,688,745 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
12,971 | $6,828,453 | |
| 7 | CDNA |
CareDx, Inc.
|
214,342 | $6,108,747 | |
| 8 | VCYT |
Veracyte, Inc.
|
94,044 | $5,523,204 |
All Filings in IMDX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,771 | 14,029 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||